DR5—FAP bispecific death receptor agonistic antibodies
US9481730B2 · kind B2 · utility
26Cited by
5References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 27, 2010 |
| Grant date | Nov 1, 2016 |
| Priority date | — |
| Expiry date | Dec 30, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/73
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to bispecific antibodies comprising a first antigen binding site specific for a death receptor and a second antigen binding site specific for a second antigen, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.